Annual report pursuant to Section 13 and 15(d)

SEGMENT INFORMATION - Reconciliation of Adjusted EBITDA to Net Income (Details)

v3.24.3
SEGMENT INFORMATION - Reconciliation of Adjusted EBITDA to Net Income (Details) - USD ($)
$ in Thousands
 1 Months Ended 3 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2022
Reconciliation Of Adjusted EBITDA To Net Income [Abstract]          
Total Adjusted EBITDA     $ 205,157 $ 225,809 $ 210,408
Non-Operating Income and Expenses [Abstract]          
Acquisition and divestiture related items     (5,576) (5,293) (7,898)
Strategic initiatives and other charges     (65,586) (13,923) (28,060)
Non-recurring / incremental COVID-19 costs     0 0 (2,985)
Highly inflationary accounting losses (primarily non-cash)     (1,027) (1,360) (1,473)
Defined benefit plan termination related items     0 0 429
Asset write-downs, net   $ (6,844) (33,574) 0 (92,504)
Goodwill and asset write-downs     (16,727) 0 (82,454)
Stock-based compensation     (18,478) (17,308) (17,432)
Non-service pension and postretirement expense     (439) (1,640) (31,823)
Depreciation and amortization     (94,770) (96,530) (104,056)
Interest expense, including RPA and factoring financing fees     (55,364) (48,690) (28,771)
Net loss attributable to noncontrolling interests     0 (155) (54)
(Loss) income before income taxes     (69,657) 40,910 (104,219)
Income tax benefit (provision)     9,997 (1,774) 4,391
Net (loss) income     (59,660) 39,136 (99,828)
Gain on divestitures     1,428 2,980 3,390
Gain (loss) on dispute     12,399    
Loss recovery       2,154  
RPA financing fees     4,830 4,042 1,046
Selling expense     141,875 140,119 128,362
Administrative expense     346,405 307,368 298,315
Accrued severance and other employee termination benefits $ 7,321 42,245 42,245 7,321  
Other Cost Reduction Initiatives, Severance and Other Employee Termination Benefits     45,705 13,210 14,596
Cost of Sales          
Non-Operating Income and Expenses [Abstract]          
Strategic initiatives and other charges     (32,526) (9,028) (1,777)
Asset write-downs, net         (9,686)
Selling Expense          
Non-Operating Income and Expenses [Abstract]          
Strategic initiatives and other charges     (1,379) (1,925) (267)
Administrative Expense          
Non-Operating Income and Expenses [Abstract]          
Strategic initiatives and other charges     (11,800) (2,257) (12,552)
Asset write-downs, net         (364)
Memorialization          
Non-Operating Income and Expenses [Abstract]          
Goodwill and asset write-downs     0    
Industrial Technologies          
Non-Operating Income and Expenses [Abstract]          
Goodwill and asset write-downs     (16,727)    
Gain on divestitures $ 1,827     1,827  
SGK Brand Solutions          
Non-Operating Income and Expenses [Abstract]          
Goodwill and asset write-downs     0    
Operating Segments | Memorialization          
Reconciliation Of Adjusted EBITDA To Net Income [Abstract]          
Total Adjusted EBITDA     162,586 163,986 151,849
Non-Operating Income and Expenses [Abstract]          
Non-recurring / incremental COVID-19 costs         (1,314)
Asset write-downs, net   (13,716)      
Depreciation and amortization     (27,768) (23,738) (23,228)
Acquisition costs, ERP integration costs, and strategic initiatives and other charges     3,514 1,002 3,517
Operating Segments | Industrial Technologies          
Reconciliation Of Adjusted EBITDA To Net Income [Abstract]          
Total Adjusted EBITDA     39,716 66,278 56,762
Non-Operating Income and Expenses [Abstract]          
Non-recurring / incremental COVID-19 costs         (6)
Goodwill and asset write-downs   (16,727)      
Depreciation and amortization     (23,772) (23,184) (11,387)
Acquisition costs, ERP integration costs, and strategic initiatives and other charges     54,357 4,108 5,631
Operating Segments | SGK Brand Solutions          
Reconciliation Of Adjusted EBITDA To Net Income [Abstract]          
Total Adjusted EBITDA     61,620 57,128 60,120
Non-Operating Income and Expenses [Abstract]          
Non-recurring / incremental COVID-19 costs         (1,199)
Asset write-downs, net         (10,050)
Goodwill and asset write-downs         82,454
Depreciation and amortization     (38,667) (44,842) (64,173)
Acquisition costs, ERP integration costs, and strategic initiatives and other charges     3,001 10,905 19,359
Segment Reporting, Reconciling Item, Corporate Nonsegment          
Reconciliation Of Adjusted EBITDA To Net Income [Abstract]          
Total Adjusted EBITDA     (58,765) (61,583) (58,323)
Non-Operating Income and Expenses [Abstract]          
Non-recurring / incremental COVID-19 costs         (466)
Depreciation and amortization     (4,563) (4,766) (5,268)
Other investment, impairment charge   $ 3,131      
Acquisition costs, ERP integration costs, and strategic initiatives and other charges     $ 10,290 $ 3,201 $ 7,451